S6K1 (RPS6KB1) Human shRNA Plasmid Kit (Locus ID 6198)

Specifications

Product Data
Product Name	S6K1 (RPS6KB1) Human shRNA Plasmid Kit (Locus ID 6198)
Locus ID	6198
UniProt ID	P23443
Synonyms	p70 S6KA; p70(S6K)-alpha; p70-alpha; p70-S6K; PS6K; S6K; S6K-beta-1; S6K1; STK14A
Vector	pRFP-C-RS
Format	Retroviral plasmids
Kit Components	RPS6KB1 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 6198). 5µg purified plasmid DNA per construct 29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free.
RefSeq	NM_001272042, NM_001272043, NM_001272044, NM_001272060, NM_003161, NM_003161.1, NM_003161.2, NM_003161.3, NM_001272043.1, NM_001272044.1, NM_001272042.1, NM_001272060.1, BC030763, BC036033, BC053365, NR_161462, NM_001369670, NM_001369673, NM_001369675, NM_001369677, NM_001369678, NR_161455, NR_161456, NR_161460, NM_001369669, NM_001369671, NM_001369672, NM_001369674, NM_001369676, NM_001369679, NR_161457, NR_161458, NR_161459, NR_161461, NM_003161.4, NM_001272043.2
Summary	This gene encodes a member of the ribosomal S6 kinase family of serine/threonine kinases. The encoded protein responds to mTOR (mammalian target of rapamycin) signaling to promote protein synthesis, cell growth, and cell proliferation. Activity of this gene has been associated with human cancer. Alternatively spliced transcript variants have been observed. The use of alternative translation start sites results in isoforms with longer or shorter N-termini which may differ in their subcellular localizations. There are two pseudogenes for this gene on chromosome 17. [provided by RefSeq, Jan 2013]
shRNA Design	These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
Performance Guaranteed	OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.